We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
AUM
$202M
AUM Growth
-$20.4M
Cap. Flow
-$72M
Cap. Flow %
-35.68%
Top 10 Hldgs %
32.61%
Holding
161
New
27
Increased
32
Reduced
22
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 28.09%
2 Healthcare 11.1%
3 Financials 3.75%
4 Consumer Discretionary 3.07%
5 Real Estate 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCOV
126
DELISTED
Brightcove, Inc.
BCOV
-95,323
Closed -$1.1M
GRTX
127
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
-472,180
Closed -$3.83M
PETV
128
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
-11,430
Closed -$31K
ATCO
129
PUT
DELISTED
Atlas Corp.
ATCO
-15,700
Closed -$9K
AVYA
130
CALL
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
-70,500
Closed -$9K
CXP
131
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
-21,972
Closed -$418K
DSPG
132
DELISTED
DSP Group Inc
DSPG
-68,154
Closed -$1.49M
ADMS
133
DELISTED
Adamas Pharmaceuticals
ADMS
-625,080
Closed -$3.1M
LUNA
134
DELISTED
Luna Innovations Incorporated
LUNA
-87,810
Closed -$834K

Similar funds

Worth Venture Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Worth Venture Partners held 161 positions worth $202M, down 9.2% from $222M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Worth Venture Partners withdrew a net $72M in Q4 2021, closing 30 positions and reducing 22 holdings. Its most notable exit was Galera Therapeutics, Inc. Common Stock, an estimated $3.83M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Worth Venture Partners opened a new position in Everspin Technologies worth $4.03M.

  • Worth Venture Partners's largest Q4 2021 buy was Everspin Technologies: 356,722 shares worth $4.03M.
  • Worth Venture Partners added most to SCYNEXIS in Q4 2021, an estimated $920K increase.
  • Worth Venture Partners's biggest Q4 2021 reduction was Emcore Corp, cutting an estimated $5.2M.
  • Worth Venture Partners fully exited Galera Therapeutics, Inc. Common Stock in Q4 2021, selling an estimated $3.83M.
  • Worth Venture Partners's ten largest holdings make up 33% of its $202M portfolio in Q4 2021.
  • Worth Venture Partners opened 27 new positions and closed 30 in Q4 2021.
  • Worth Venture Partners's portfolio value fell 9.2% quarter-over-quarter to $202M.

Based on Worth Venture Partners's 13F filing for Q4 2021, filed 14 Feb 2022.